US orders 200 mn more Pfizer-BioNTech vaccine doses

The United States will purchase 200 million more COVID-19 vaccine doses from Pfizer and BioNTech and has an option to buy additional doses to address virus variants, the companies announced Friday.

Medical research

Data disarray damages COVID-19 response, expert says

Throughout our work at the Coronavirus Resource Center, we have highlighted that state reporting methods for COVID-19 testing, hospitalization, death, and vaccination data are limited by lack of standardization and accessibility. ...

Diseases, Conditions, Syndromes

Diabetics hit harder by COVID-19

People with type 2 diabetes are at significantly elevated risk of needing intensive care if they get COVID-19. This is shown by a study comprising data on 2.6 million Swedes, of whom half a million are on the diabetes register. ...

page 1 from 7